Pricing Log in Create free account

Cybin Inc. (HELP) vs Immix Biopharma, Inc. (IMMX)

Cybin Inc. and Immix Biopharma, Inc. are both Biotechnology companies. Cybin Inc. and Immix Biopharma, Inc. are of similar size ($613.0M and $596.9M). Across the 9 metrics below, Immix Biopharma, Inc. leads on 6 and Cybin Inc. on 3.

Valuation

Metric HELP IMMX Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 1.94 2.23 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (47.34%) (10.97%) (32.88%)
Free cash flow yield (30.48%) (7.64%) (23.13%)

Profitability

Metric HELP IMMX Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (86.94%) (34.18%) (51.96%)
Return on assets (72.78%) (31.34%) (46.06%)
Return on invested capital (137.88%) 0.00% 0.00%

Growth

Metric HELP IMMX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (5.72%) (17.11%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HELP IMMX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 10.97 25.13 4.97
Net debt to EBITDA 1.10 3.39 1.01

Dividend

Metric HELP IMMX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric HELP IMMX Biotechnology median
Market cap 612.97m 596.90m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack